股票/基金 实时行情 股吧

简称:普利制药 代码:300630


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,508,829,421.63428,853,759.551,079,975,662.0871.58
其他2,880,497.762,094,297.90786,199.8627.29
医药制造业1,505,948,923.87426,759,461.651,079,189,462.2271.66

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,188,603,424.51300,033,041.93888,570,382.5874.76
其他2,784,196.182,283,073.64501,122.5418.00
医药制造业1,185,819,228.33297,749,968.29888,069,260.0474.89

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计950,095,207.86174,764,325.79775,330,882.0781.61
医药制造业950,095,207.86174,764,325.80775,330,882.0681.61

会计年度:2019-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
非甾体34,074,862.364,715,315.0729,359,547.2986.16
抗过敏141,493,380.8013,366,540.82128,126,839.9890.55
抗生素101,487,896.1018,528,627.6082,959,268.5081.74
其他74,814,498.6918,444,989.6556,369,509.0475.35

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计623,904,151.91101,351,502.15522,552,649.7683.76
医药制造业623,904,151.91101,351,502.15522,552,649.7683.76

    1/2 转到